These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16312354)

  • 1. Microbiological studies on lomefloxacin--a new quinolone.
    Newsom SW; Rowland C
    J Chemother; 1989 Jul; 1(4 Suppl):168-9. PubMed ID: 16312354
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro antimicrobial activity of lomefloxacin against staphylococci, enterococci, and Enterobacteriaceae.
    Rossolini GM; Valentini S; Vaiani G; Satta G
    J Chemother; 1989 Jul; 1(4 Suppl):173-6. PubMed ID: 16312356
    [No Abstract]   [Full Text] [Related]  

  • 3. Antimicrobial activity of a new difluorinated quinolone: lomefloxacin (SC-47111).
    Mattina R; Cocuzza G; Cocuzza CE
    J Chemother; 1989 Jul; 1(4 Suppl):159-61. PubMed ID: 16312351
    [No Abstract]   [Full Text] [Related]  

  • 4. Lomefloxacin (SC 47111 or NY-198), a new difluorinated quinolone: comparison of the in vitro activity with other broad spectrum antimicrobials against Enterobacteriaceae, Acinetobacter spp, Aeromonas spp, and Pseudomonas aeruginosa.
    Aldridge KE; Henderberg A; Sanders CV
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):1S-6S. PubMed ID: 2507219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative activity of three new fluoroquinolones.
    Coll R; Esteve M; Moros M; Parés J; Xicota MA
    Chemioterapia; 1987 Jun; 6(2 Suppl):152-3. PubMed ID: 3509374
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro evaluation of lomefloxacin (NY-198 or SC-47111), a new difluoro-quinolone.
    Jones RN
    J Chemother; 1989 Jul; 1(4 Suppl):165-7. PubMed ID: 16312353
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro activity of lomefloxacin, a new difluorinated quinolone, against urinary bacterial isolates: comparison with enoxacin and ofloxacin.
    Azadian BS; Talboys CA; Roberts AP
    J Chemother; 1989 Jul; 1(4 Suppl):176-7. PubMed ID: 16312357
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro evaluation of lomefloxacin activity in Colombia.
    Trujillo H; Mejia GI; Castrillon L; Gomez C
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):51S-52S. PubMed ID: 2791498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External otitis in divers: etiology and in vitro activity of ciprofloxacin and local agents.
    Dibb WL
    Chemioterapia; 1987 Jun; 6(2 Suppl):138-40. PubMed ID: 3509371
    [No Abstract]   [Full Text] [Related]  

  • 10. Susceptibility of canine and feline Escherichia coli and canine Staphylococcus intermedius isolates to fluoroquinolones.
    Gottlieb S; Wigney DI; Martin PA; Norris JM; Malik R; Govendir M
    Aust Vet J; 2008 Apr; 86(4):147-52. PubMed ID: 18363989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial activity of fluoroquinolones in combination with zidovudine.
    Lewin CS; Allen RA; Amyes SG
    J Med Microbiol; 1990 Oct; 33(2):127-31. PubMed ID: 2121991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro activity of lomefloxacin (SC 47111 or NY-198) against fresh clinical bacterial isolates.
    Wright DN; Saxon B; Matsen JM
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):7S-11S. PubMed ID: 2791501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiological studies on cefoperazone.
    Kayser FH
    Clin Ther; 1980; 3(Spec Issue):24-33. PubMed ID: 6446395
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibacterial and plasmid curing activity of lomefloxacin in vitro.
    Derlot E; Poyart-Salmeron C; Courvalin P
    Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1048-52. PubMed ID: 2515963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of ofloxacin in the treatment of suppurative-inflammatory complications in surgery].
    Bogomolova NS; Bol'shakov LV; Vinogradova LN; Sorokina VI; Oreshkina TD; Tret'iakova ES
    Anesteziol Reanimatol; 1997; (3):18-20. PubMed ID: 9289979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of subinhibitory concentrations of lomefloxacin on bacterial adherence.
    Ravizzola G; Longo M; Pollara P; De Francesco M; Pizzi R
    New Microbiol; 1994 Jul; 17(3):211-6. PubMed ID: 7968656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of quinolone-resistant Escherichia coli found in major rivers in Korea.
    Jung D; Lee MY; Kim JM; Lee JC; Cho DT; Lee Y
    J Microbiol; 2006 Dec; 44(6):680-4. PubMed ID: 17205049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacodynamic and pharmacokinetic approaches to optimization of lomefloxacin].
    Iakovlev SV
    Antibiot Khimioter; 1998; 43(10):42-5. PubMed ID: 9825110
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antibacterial and pharmacokinetic actions of amoxicillin].
    Duval J; Soussy CJ
    Nouv Presse Med; 1975 Oct; 4(34):2433-6. PubMed ID: 812057
    [No Abstract]   [Full Text] [Related]  

  • 20. In-vitro activity of OPC-17116 against bacterial enteric pathogens.
    Arduino RC; Frosolono M; Murray BE
    J Antimicrob Chemother; 1994 Sep; 34(3):403-7. PubMed ID: 7829414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.